Canoe Financial LP Buys 194,555 Shares of CVS Health Corporation $CVS

Canoe Financial LP lifted its stake in shares of CVS Health Corporation (NYSE:CVS) by 11.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,899,163 shares of the pharmacy operator’s stock after acquiring an additional 194,555 shares during the period. CVS Health makes up about 2.0% of Canoe Financial LP’s investment portfolio, making the stock its 16th largest holding. Canoe Financial LP owned about 0.15% of CVS Health worth $150,718,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. Cypress Wealth Services LLC acquired a new stake in shares of CVS Health in the 4th quarter valued at about $229,000. Eastern Bank boosted its position in shares of CVS Health by 20.3% during the fourth quarter. Eastern Bank now owns 10,575 shares of the pharmacy operator’s stock worth $839,000 after buying an additional 1,784 shares during the period. Waldron Private Wealth LLC boosted its position in shares of CVS Health by 19.7% during the fourth quarter. Waldron Private Wealth LLC now owns 4,460 shares of the pharmacy operator’s stock worth $354,000 after buying an additional 733 shares during the period. Pallas Capital Advisors LLC grew its holdings in shares of CVS Health by 1.6% during the fourth quarter. Pallas Capital Advisors LLC now owns 22,237 shares of the pharmacy operator’s stock worth $1,765,000 after buying an additional 342 shares in the last quarter. Finally, Net Worth Advisory Group acquired a new stake in CVS Health in the 4th quarter valued at approximately $792,000. 80.66% of the stock is currently owned by institutional investors and hedge funds.

CVS Health Trading Down 1.5%

Shares of CVS Health stock opened at $70.08 on Friday. The stock has a market cap of $89.16 billion, a P/E ratio of 50.79, a P/E/G ratio of 0.73 and a beta of 0.49. The company has a quick ratio of 0.63, a current ratio of 0.84 and a debt-to-equity ratio of 0.80. CVS Health Corporation has a 12-month low of $58.35 and a 12-month high of $85.15. The business’s 50 day moving average is $76.62 and its 200-day moving average is $77.77.

CVS Health (NYSE:CVS) last released its earnings results on Tuesday, February 10th. The pharmacy operator reported $1.09 earnings per share for the quarter, beating the consensus estimate of $1.00 by $0.09. The business had revenue of $105.69 billion during the quarter, compared to analysts’ expectations of $103.67 billion. CVS Health had a net margin of 0.44% and a return on equity of 11.31%. The firm’s revenue was up 8.2% on a year-over-year basis. During the same period last year, the business earned $1.19 earnings per share. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. Equities research analysts predict that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, May 4th. Stockholders of record on Thursday, April 23rd will be paid a dividend of $0.665 per share. The ex-dividend date is Thursday, April 23rd. This represents a $2.66 annualized dividend and a dividend yield of 3.8%. CVS Health’s payout ratio is currently 192.75%.

Analysts Set New Price Targets

A number of equities analysts have weighed in on CVS shares. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of CVS Health in a research report on Monday, December 29th. Wolfe Research cut their price objective on shares of CVS Health from $100.00 to $97.00 and set an “outperform” rating on the stock in a research report on Monday, March 2nd. Argus reduced their target price on shares of CVS Health from $91.00 to $90.00 and set a “buy” rating for the company in a report on Wednesday, January 28th. Robert W. Baird raised their target price on shares of CVS Health from $82.00 to $92.00 and gave the company an “outperform” rating in a research report on Wednesday, December 10th. Finally, Piper Sandler reissued an “overweight” rating and set a $101.00 price target (up from $99.00) on shares of CVS Health in a research report on Wednesday, December 10th. Twenty research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $95.05.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.